Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
Motley Fool
Tue, 07/28/20 - 11:14 am
Tags:
AstraZeneca, DS-1062, Daiichi Sankyo
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
Mon, 07/27/20 - 11:00 am
Tags:
AstraZeneca, Daiichi Sankyo, DS-1062, antibodies, cancer
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Thu, 07/2/20 - 11:09 am
Tags:
Daiichi Sankyo, antibody-drug conjugate, triple negative breast cancer, DS-1062, clinical trials
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine hopeful
Fierce Pharma
Fri, 06/26/20 - 01:04 pm
Tags:
AstraZeneca, Daiichi Sankyo, University of Oxford, vaccines, COVID-19, Japan
Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC
BioSpace
Tue, 06/23/20 - 11:39 pm
Tags:
Daiichi Sankyo, Thermo Fisher, companion diagnostics, diagnostics, non-small cell lung cancer
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Tags:
Daiichi Sankyo, AstraZeneca, Enhertu, stomach cancer, colorectal cancer, lung cancer, ASCO 2020
AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week
Pharmaforum
Mon, 05/18/20 - 10:49 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertus, metastatic non-small-cell lung cancer
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
Tags:
AstraZeneca, Daiichi Sankyo, FDA, Enhertu, gastric cancer, breakthrough therapy
Daiichi Sankyo submits application for CAR T therapy axicabtagene ciloleucel to treat patients with certain relapsed/refractory B-cell lymphomas in Japan
Pharmaceutical Business Review
Tue, 03/31/20 - 11:05 am
Tags:
Daiichi Sankyo, Japan, CAR-T, axicabtagene ciloleucel, relapsed or refractory diffuse large B-cell lymphoma
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, clinical trials, HER2-positive non-small cell lung cancer
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
Tags:
AstraZeneca, Daiichi Sankyo, clinical trials, FDA, Enhertu, cancer, breast cancer
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
Tags:
antibody-drug conjugate, AstraZeneca, Daiichi Sankyo, Enhertu
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
Tags:
AstraZeneca, breast cancer, Daiichi Sankyo, trastuzumab deruxtecan, gastric cancer
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
Tags:
FDA, AstraZeneca, Daiichi Sankyo, advanced breast cancer, Enhertu
Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals
BioPharma Dive
Fri, 12/20/19 - 08:19 pm
Tags:
Daiichi Sankyo, AstraZeneca, FDA, drug approvals, breast cancer, trastuzumab deruxtecan
SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance
EP Vantage
Wed, 12/11/19 - 10:24 am
Tags:
breast cancer, AstraZeneca, Daiichi Sankyo, SABCS, trastuzumab deruxtecan
Seattle Genetics Claims Arbitration Rights in Daiichi Sankyo ADC Dispute
BioSpace
Tue, 12/3/19 - 10:29 pm
Tags:
Seattle Genetics, Daiichi Sankyo, antibody-drug conjugate
Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug
Endpoints
Fri, 11/8/19 - 10:40 am
Tags:
Daiichi Sankyo, Exelixis, clinical trials, diabetic nephropathy, Minnebro
Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates
Pharmaforum
Wed, 11/6/19 - 10:18 am
Tags:
Daiichi Sankyo, Seattle Genetics, breast cancer, AstraZeneca, trastuzumab deruxtecan, Herceptin
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Fierce Biotech
Tue, 11/5/19 - 10:34 am
Tags:
Daiichi Sankyo, Seattle Genetics, antibody-drug conjugate, AstraZeneca, DS-8201

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.